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Abstract 
 
Background 
 
The HeartMate II Left Ventricular Assist Device (LVAD) receives power via a 
percutaneous lead connected to an external controller and batteries. At times, this 
lead can be damaged during normal wear, as well as by traumatic fracture, which 
may jeopardize the functionality of the LVAD. If there is significant internal 
damage, surgical replacement of the LVAD is required. However it is possible to 
repair externally damaged leads by replacing the distal portion of the lead to avoid 
pump replacement. We report the overall experience and outcomes in patients 
with external lead repairs. 
Methods 
A procedure for full external lead replacement has been developed and is 
approved for implementation by the FDA. Pre-procedural steps include 
examination of high resolution x-rays of the driveline and analysis of pump log 
files. Efficacy and outcomes of all attempted external lead repairs were evaluated 
between initiation of repairs in 2008 through 2014. 
Results 
A total of 321 repairs were attempted in 297 patients with suspected isolated 
external lead damage after a median of 2.0 yr [range: 7d to 8.7 yr] of support. Of 
297 patients, 37 (12.5%) had attempts at external repair that were unsuccessful 
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due to concomitant internal lead damage. 31 patients (10.4%) had additional 
serious malfunctions after lead repair resulting in 17 with repeat repairs and 14 
who continued on ungrounded cables, and ultimately 14 of these 31 patients 
required pump exchanges. 27 of the 297 patients (9.1%) with lead repairs had only 
minor additional problems, including cuts or abrasion in the insulation which was 
fixed with tape or external reinforcement. There was one catastrophic failure 
during attempted lead repair requiring emergent pump exchange, and there were 
three deaths within 14 days of attempted repair related to continued percutaneous 
lead damage. One of these patients refused pump exchange, and two were not 
candidates for other clinical reasons. 202 of the 297 patients (68%) have had no 
recurrence of lead problems after a median follow-up of 189 days [n=11 over 2 
years, longest 5.8 yr]. 
Conclusions 
HeartMate II dysfunction due to percutaneous lead damage is uncommon but is of 
serious concern due to potential abrupt pump stoppage. Lead repair by 
replacement of the external distal percutaneous lead can be performed by trained 
personnel in a standardized fashion and may provide a durable solution in select 
patients with isolated external lead damage, thus avoiding the need for surgical 
pump exchange. We provide an algorithm for evaluating potential lead damage. 
Keywords: LVAD, percutaneous lead, repair, ventricular assist device 
 
 
Background  
 
The HeartMate II  (St Jude Medical, Pleasanton, CA, previously Thoratec 
Corporation) is currently the only left ventricular assist device approved by the 
FDA for both bridge to heart transplantation and destination therapy. The pivotal 
trials for bridge to transplantation and destination therapy demonstrated 
significantly improved reliability compared to earlier pulsatile volume displacement 
devices and minimal bearing wear in explanted pumps1–3. To date, over 20,000 
implants have been performed worldwide, and nearly 8,000 patients remain on 
support. With an increasing proportion of patients being implanted as destination 
therapy with longer durations of support, physical wear on the external 
components are emerging as a factor in long-term durability. The HeartMate II 
LVAD, like other LVADs, is dependent on the externalized lead for electrical power 
and control of pump settings. The percutaneous lead is susceptible to physical 
damage, which may manifest as pump speed or power fluctuations, alarms, device 
malfunction, or at worst, potentially catastrophic abrupt pump stoppage. Due to 
these limitations, a new pump design of the HeartMate 3 has incorporated 
modularity in the external lead to mitigate this possibility4. 
The HeartMate II percutaneous lead consists of three pairs of redundant wires that 
are electrically shielded and protected by two water-resistant jackets (Figure 1). 
The internal wiring schematic is shown in Figure 2. Damage to the external lead by 
repeated flexion can be manifested by retraction of the silver-coated copper 
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braided shield and fracture of an individual wire (Figure 3). Damage to the braided 
shield without internal wire fracture, can lead to a phenomenon known as short-to-
shield, which can result in pump dysfunction when connected to a grounded power 
source5. There is also the possibility of a short between two different motor leads 
by the shield wires which cause pump stoppage even if a non-grounded shield 
cable is used. 
Figure	1:	Schematic	of	HeartMate	II	percutaneous	lead	
	
	  
Figure	2:		Internal	wiring	diagram	of	HeartMate	II	percutaneous	lead
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Traditionally, damage to the external lead not resulting in pump dysfunction was 
treated by external reinforcement of the driveline. Damage of the driveline causing 
abnormal LVAD function typically required LVAD exchange, usually through a 
repeat sternotomy, but more recently via a subcostal approach6–14. In 2009, 
Thoratec (St. Jude) developed a procedure for external driveline repair to reduce 
the need for pump exchange procedures. We reviewed the aggregate clinical 
experience to date of external driveline repairs of HeartMate II LVADs. 
 
 
 
 
 
The VAD Journal: http://dx.doi.org/10.13023/VAD.2016.14 Page 4 of 11 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
Figure	3:	Damage	to	the	external	lead	by	repeated	flexion	can	be	manifested	by	
retraction	of	the	silver-coated	copper	braided	shield	and	fracture	of	an	individual	
wire	(orange).
	
	  
 
Methods 
 
A retrospective review was undertaken of all percutaneous lead repairs performed 
by the St Jude Medical Technical Services Team. The HeartMate II log file for 
each patient was reviewed for alarms, unexplained pump stoppages, pump speed 
and/or power fluctuations. Each patient initially underwent a controller exchange 
and close examination of visible connectors to ensure adequate contact.  A 
radiograph of the externalized portion of the percutaneous lead was obtained, and 
examined for evidence of broken wires or abnormal shielding. If external damage 
was identified (Figure 4), preparation for repair by St. Jude Medical personnel was 
undertaken. 
A procedure for external percutaneous lead replacement was developed and 
approved for implementation by the U.S. Food and Drug Administration. The repair 
technique involves removing the silastic covering from the driveline, separating 
each pair of wires, and splicing a new lead to the damaged set of wires (Figure 5). 
The pump continues to function on the intact wires of the original lead. The new 
lead is then tested, and control transferred to the new controller. The second set of 
wires is then transferred to the new lead, and the repaired section is re-insulated 
and encapsulated in a water-resistant enclosure (Figure 6). Of note, the external 
percutaneous lead repair requires approximately 15cm from the skin exit site, and 
must not include any velour-covered areas. 
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Patients who underwent external driveline replacement were then followed 
clinically to determine success of repair, durability, and potential need for further 
intervention on the percutaneous lead or pump exchange. 
Figure 4: Radiographs of lead damage 
 
 
Figure	5:	Repair	of	external	percutaneous	lead	
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Figure	6:	Completed	percutaneous	lead	repair		
	
	  
Results 
Between January 1, 2008, when the external percutaneous lead repair procedure 
was initiated, until December 31, 2014, a total of 321 repairs were undertaken in 
297 patients. The median duration of mechanical support prior to the repair 
procedure was 2.0 years (range 7days -8.7 years). 202 of the 297 (68%) patients 
had resolution of pump dysfunction with no recurrence of lead problems. The 
median duration of support after lead replacement was 189 days, with 11 patients 
greater than two years. Twenty-seven of 297 (9.2%) of patients had minor 
additional problems such as abrasions of the insulation without electrical damage 
that were repaired with tape and external reinforcement. 
Thirty-seven (12.5%) patients had unsuccessful external replacement of the 
percutaneous lead due to concomitant intracorporeal lead damage. Thirty-one 
(10.4%) patients continued with serious malfunctions after lead replacement. Of 
these, 17 patients underwent repeat repair, and 14 continued on ungrounded 
cables. Fourteen of these 31 patients ultimately underwent pump exchange (Table 
1). 
One patient required emergent pump exchange due to catastrophic failure during 
the external lead replacement procedure. In this specific instance, there was a 
concomitant internal driveline fracture that had not been detected prior to external 
repair. There were three deaths within 14 days of attempted lead repair due to 
ongoing lead damage and electrical malfunction of the LVAD. One patient refused 
pump exchange, and the other two were deemed not candidates for repair due to 
clinical reasons. 
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Table	1:	
Repair	Outcome	 Number	(%)	
Successful	without	additional	intervention	 202	(68)	
Successful	with	minor	additional	repair	 27	(9.1)	
Additional	serious	malfunctions	 31	(10.4)	
Repeat	Repair	 17	
Continue	support	on	ungrounded	cable	 14	
Unsuccessful	 37	(12.5)	
	
       Discussion  
Since approval of the HeartMate II LVAD in 2008, more than 20,000 implants have 
been performed. During this period, an increasing number of patients are 
implanted as Destination Therapy, and extended durations of support are 
becoming the norm. This has led to longer time periods during which the external 
percutaneous lead is exposed to physical damage.  
Early experience with external percutaneous lead failures were exclusively treated 
with urgent pump exchange procedures15. While exchange procedures can 
typically be performed safely, there remains additional risk from the repeat surgical 
procedure, as well as the financial impact of that care episode. Stulak and 
colleagues reported on a series of LVAD exchanges and found that while the 
operative mortality was encouragingly low (3.5%), patients were at risk for late 
mortality, increased morbidity and frequently repeated device exchange16. In 
addition, Moazami et al reported on a series of LVAD exchanges, and found that 
30% of patients ultimately died within one year of pump exchange17. Despite this, 
Anand et al found that pump exchange prolonged support time in a manner similar 
to the original implant18.  Kalavrouziotis and colleagues recently reported on the 
incidence of percutaneous lead failures among patients supported with HeartMate 
II LVADs and found that 9.2% of implanted pumps developed lead damage19. They 
concluded that lead failures played a significant role in the long-term durability of 
left ventricular assist devices. Two significant revisions in the percutaneous lead 
design, in 2007 and 2012, have reduced the incidence of lead failure. 
We report on the external percutaneous lead repair technique and associated 
long-term outcomes of patients supported on repaired leads. Isolated external lead 
damage can be successfully repaired in a significant number of patients, thereby 
avoiding the morbidity and mortality risk of a pump-exchange procedure. In some 
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patients, additional minor repairs (such as external reinforcement) are necessary, 
while others may require more extensive additional repair. In rare occasions, a 
patient is maintained on an ungrounded cable to prevent short-to-shield 
phenomena. The incidence of abrupt pump stoppage during the repair procedure 
is exceedingly rare.  
A cohort of patients experienced ongoing pump dysfunction after lead repair, 
necessitating LVAD exchange. This could be due to concomitant intracorporeal 
lead fracture, or other electrical damage not grossly visible on examination of the 
driveline. Therefore, we recommend comprehensive and careful radiographic 
evaluation to ensure that the intracorporeal portion of the percutaneous lead is 
intact, and that areas not easily visible on radiographs are directly examined prior 
to proceeding with external percutaneous lead repair. 
Our algorithm to evaluate suspected percutaneous lead damage is to analyze the 
pump log files for evidence of pump speed or power fluctuations, unexplained 
pump stoppage, or alarms (Figure 7). If concern exists for an electrical malfunction 
of the left ventricular assist system, comprehensive radiographs are obtained of 
the external component of the driveline. Computed tomography may be required 
for evaluation of the internal portion of the percutaneous lead. If a lead fracture if 
the external part is identified, the St Jude Medical Technical Services Team is 
called to perform an external lead repair. Internal lead damage must be excluded 
prior to external repair to avoid the possibility of abrupt pump stoppage during 
repair or persistent pump malfunction. We perform the repair procedure in patient’s 
room in an intermediate care telemetry unit or intensive care unit. Given the low 
likelihood of pump stoppage, we do not routinely take precautions, such as 
surgical stand-by for emergent pump exchange. 
Limitations 
The true denominator of percutaneous lead failures may be underestimated by this 
methodology.  Additionally, since this procedure is relatively recent in the history of 
the HeartMate II, there were patients who underwent pump exchange despite 
having repairable external leads.  Further, since there are regions of the 
percutaneous lead that are not easily visible on radiographic examination, there 
may be additional patients who may have benefitted from this repair technique. 
Conclusions 
Replacement of the external percutaneous lead by the St Jude Medical Technical 
Support Team can be performed safely, and in most instances, can resolve 
electrical malfunction of the LVAD associated with a fracture in the external 
component of the lead, and in the absence of an internal lead fracture. This repair 
has been shown to be effective and durable. In patients with no evidence of 
internal lead fracture, and in whom other causes of electrical failure have been 
excluded, we believe that external lead repair should be attempted prior to pump 
exchange.  
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Figure 7: Algorithm 
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